9.25
                                            Schlusskurs vom Vortag:
              $9.29
            Offen:
              $9.48
            24-Stunden-Volumen:
                175.49K
            Relative Volume:
              1.71
            Marktkapitalisierung:
                $151.13M
            Einnahmen:
              -
            Nettoeinkommen (Verlust:
              $-33.82M
            KGV:
              -0.3615
            EPS:
                -25.5891
            Netto-Cashflow:
                $-66.04M
            1W Leistung:
              -4.64%
            1M Leistung:
              -16.21%
            6M Leistung:
                +68.18%
            1J Leistung:
              +101.53%
            Elicio Therapeutics Inc Stock (ELTX) Company Profile
Firmenname
                  
                      Elicio Therapeutics Inc
                    
                Sektor
                  Branche
                  Telefon
                  
                      (857) 209-0050
                    
                Adresse
                  
                      451 D STREET, 5TH FLOOR, BOSTON
                    
                Vergleichen Sie ELTX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV | 
|---|---|---|---|---|---|---|
| 
                         
                          
                                ELTX
                            
                             
                        Elicio Therapeutics Inc 
                           | 
                    9.25 | 151.78M | 0 | -33.82M | -66.04M | -25.59 | 
| 
                         
                          
                                VRTX
                            
                             
                        Vertex Pharmaceuticals Inc 
                           | 
                    426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 | 
| 
                         
                          
                                REGN
                            
                             
                        Regeneron Pharmaceuticals Inc 
                           | 
                    642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 | 
| 
                         
                          
                                ALNY
                            
                             
                        Alnylam Pharmaceuticals Inc 
                           | 
                    434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 | 
| 
                         
                          
                                ARGX
                            
                             
                        Argen X Se Adr 
                           | 
                    826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 | 
| 
                         
                          
                                INSM
                            
                             
                        Insmed Inc 
                           | 
                    186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 | 
Elicio Therapeutics Inc Aktie (ELTX) Neueste Nachrichten
Statistical indicators supporting Elicio Therapeutics Inc.’s strengthJuly 2025 News Drivers & Expert Approved Momentum Trade Ideas - newser.com
Will Elicio Therapeutics Inc. outperform the marketJuly 2025 Spike Watch & Long-Term Investment Growth Plans - newser.com
How Elicio Therapeutics Inc. (9HA) stock moves in volatile trading sessionsMarket Sentiment Report & Daily Volume Surge Signals - newser.com
Elicio (NASDAQ: ELTX) to present late-breaking Phase 2 ELI-002 data at SITC 2025 - Stock Titan
Key metrics from Elicio Therapeutics Inc.’s quarterly dataMarket Rally & Low Drawdown Investment Ideas - newser.com
Can Elicio Therapeutics Inc. stock outperform in 2025 bull marketInsider Selling & Weekly Watchlist for Consistent Profits - newser.com
Using economic indicators to assess Elicio Therapeutics Inc. potentialJuly 2025 Momentum & Safe Investment Capital Preservation Plans - newser.com
Is Elicio Therapeutics Inc. stock oversold or undervalued2025 Volatility Report & Growth Focused Entry Point Reports - newser.com
Is Elicio Therapeutics Inc. (9HA) stock bottoming after sell offBull Run & Expert-Curated Trade Recommendations - newser.com
What valuation multiples suggest for Elicio Therapeutics Inc. stockMarket Volume Report & Safe Swing Trade Setups - newser.com
Can Elicio Therapeutics Inc. (9HA) stock attract ESG investmentsEarnings Overview Summary & Low Drawdown Momentum Trade Ideas - newser.com
Can Elicio Therapeutics Inc. stock weather global recessionQuarterly Profit Report & Daily Entry Point Trade Alerts - newser.com
How high can Elicio Therapeutics Inc. stock goEarnings Recap Report & Daily Growth Stock Tips - newser.com
Analyzing net buyer seller activity in Elicio Therapeutics Inc.Watch List & Entry Point Confirmation Signals - newser.com
How Elicio Therapeutics Inc. stock compares to market leadersEarnings Overview Report & Fast Momentum Stock Entry Tips - newser.com
Elicio Therapeutics, Inc. (ELTX) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Elicio Therapeutics Inc. stock trendline breakdownEntry Point & Risk Managed Investment Signals - newser.com
What earnings revisions data tells us about Elicio Therapeutics Inc.Weekly Gains Report & Capital Efficient Trade Techniques - newser.com
Is Elicio Therapeutics Inc. stock poised for growthFed Meeting & Risk Managed Investment Entry Signals - newser.com
How Elicio Therapeutics Inc. (9HA) stock reacts to fiscal policies2025 Market Outlook & Fast Momentum Stock Entry Tips - newser.com
What makes Elicio Therapeutics Inc. (9HA) stock appealing to growth investorsTrade Analysis Report & Long-Term Safe Return Strategies - newser.com
Finanzdaten der Elicio Therapeutics Inc-Aktie (ELTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
        In Yahoo öffnen
        |
        In Google öffnen
            |
            In Finviz öffnen
        |
        In MarketWatch öffnen
            |
            Öffnen Sie in EDGAR    
        |
        Offen in Reuters
    
    
                Kapitalisierung:
                 
                  | 
                Volumen (24h):